Monroe Facility

Glenmark Pharma Rises 3% on USFDA Approval for Monroe Facility

The US Food & Drug Administration (USFDA) provided its first supplemental abbreviated new drug application (sANDA) approval for the company’s manufacturing facility in Monroe, North Carolina. Shares of Glenmark Pharma rose 3% as the company received the USFDA’s approval for its Monroe facility.